Aspirin, PIK3CA Mutation, and Colorectal-Cancer Survival REPLY

被引：0
|
作者：
Ogino, Shuji [1 ]
Liao, Xiaoyun [1 ]
Chan, Andrew T. [2 ]
机构：
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
NEW ENGLAND JOURNAL OF MEDICINE | 2013年 / 368卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：289 / 290
页数：2
相关论文
共 50 条
  • [1] Aspirin Use, Tumor PIK3CA Mutation, and Colorectal-Cancer Survival
    Liao, Xiaoyun
    Lochhead, Paul
    Nishihara, Reiko
    Morikawa, Teppei
    Kuchiba, Aya
    Yamauchi, Mai
    Imamura, Yu
    Qian, Zhi Rong
    Baba, Yoshifumi
    Shima, Kaori
    Sun, Ruifang
    Nosho, Katsuhiko
    Meyerhardt, Jeffrey A.
    Giovannucci, Edward
    Fuchs, Charles S.
    Chan, Andrew T.
    Ogino, Shuji
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (17): : 1596 - 1606
  • [2] Aspirin Therapy for Colorectal Cancer With PIK3CA Mutation: Simply Complex!
    Fuchs, Charles S.
    Ogino, Shuji
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (34) : 4358 - 4361
  • [3] Aspirin and PIK3CA Mutations in Colorectal Cancer
    Kirstein, M. M.
    Vogel, A.
    [J]. ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2014, 52 (03): : 306 - 307
  • [4] PIK3CA mutation is predictive of poor survival in patients with colorectal cancer
    Kato, Shunsuke
    Iida, Satoru
    Higuchi, Tetsuro
    Ishikawa, Toshiaki
    Takagi, Yoko
    Yasuno, Masamichi
    Enomoto, Masayuki
    Uetake, Hiroyuki
    Sugihara, Kenichi
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2007, 121 (08) : 1771 - 1778
  • [5] Association of aspirin use with improved 5-year survival in colorectal cancer patients with PIK3CA mutation
    Kothari, Nishi
    Yeatman, Timothy Joseph
    Fisher, Kate
    Schell, Michael J.
    Kim, Richard D.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [6] PIK3CA mutation and colorectal cancer precision medicine
    Hamada, Tsuyoshi
    Nowak, Jonathan A.
    Ogino, Shuji
    [J]. ONCOTARGET, 2017, 8 (14) : 22305 - 22306
  • [7] Impact of regular aspirin use on overall and cancer-specific survival in patients with colorectal cancer harboring a PIK3CA mutation
    Kothari, Nishi
    Kim, Richard
    Jorissen, Robert N.
    Desai, Jayesh
    Tie, Jeanne
    Wong, Hui-Li
    Farragher, Ian
    Jones, Ian
    Day, Fiona L.
    Li, Shan
    Sakthinandeswaren, Anuratha
    Palmieri, Michelle
    Lipton, Lara
    Schell, Michael
    Teer, Jamie K.
    Shibata, David
    Yeatman, Timothy
    Sieber, Oliver M.
    Gibbs, Peter
    Tran, Ben
    [J]. ACTA ONCOLOGICA, 2015, 54 (04) : 487 - 492
  • [8] PIK3CA in colorectal cancer
    Cathomas, Gieri
    [J]. FRONTIERS IN ONCOLOGY, 2014, 4
  • [9] PIK3CA mutation and methylation influences the outcome of colorectal cancer
    Iida, Satoru
    Kato, Shunsuke
    Ishiguro, Megumi
    Matsuyama, Takatoshi
    Ishikawa, Toshiaki
    Kobayashi, Hirotoshi
    Higuchi, Tetsuro
    Uetake, Hiroyuki
    Enomoto, Masayuki
    Sugihara, Kenichi
    [J]. ONCOLOGY LETTERS, 2012, 3 (03) : 565 - 570
  • [10] Aspirin use and survival outcomes in patients (pts) with PIK3CA mutant colorectal cancer (CRC)
    Ben Tran
    Jorissen, Robert N.
    Desai, Jayesh
    Day, Fiona
    Lipton, Lara Rachel
    Wong, Hui-Li
    Tie, Jeanne
    Faragher, Ian
    Jones, Ian
    Sieber, Oliver
    Gibbs, Peter
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345